Top Markets
Coin of the day
Q BioMed Inc. Q BioMed Inc.

Q BioMed Inc.

QBIO
Peringkat dalam Saham #41615
Q BioMed Inc. functions as a biomedical accelerator and developer, actively... Q BioMed Inc. functions as a biomedical accelerator and developer, actively licensing, acquiring, and supplying resources to firms within the life sciences and healthcare sectors. Its commercial portfolio includes Metastron (Strontium Chloride SR89), a radiopharmaceutical designed to alleviate pain associated with metastatic bone cancer. Additionally, Q BioMed is advancing a pipeline of therapeutic candidates, including Man-01, a pre-clinical compound aimed at primary open-angle glaucoma; QBM-001, intended for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B, which targets liver cancer. The company also collaborates with Mannin Research Inc. on the development of treatments for conditions such as acute respiratory distress syndrome, glaucoma, and various kidney diseases. Incorporated in New York, New York, in 2013, the entity was initially named ISMO Tech Solutions, Inc. before adopting its current name, Q BioMed Inc., in July 2015.
Harga Saham
$0.0001
Terakhir disinkronkan: 2026-04-02
Kapitalisasi Pasar
$14.51K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
9,900.00%
Negara
US
Perdagangan Q BioMed Inc. (QBIO)

Kategori

Riwayat pemecahan saham untuk Q BioMed Inc. (QBIO)
Saham Q BioMed Inc. (simbol: QBIO) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 13, 2026.
Satu lembar saham QBIO yang dibeli sebelum Aug 13, 2026 sekarang setara dengan 0 lembar saham QBIO.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR